A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
Open Access
- 1 November 2021
- journal article
- research article
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 14, 4609-4617
Abstract
Introduction: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19 Treatment Units (CTU) in Uganda. Methods: A hospital-based descriptive cross-sectional study was conducted recruiting patients with COVID-19 hospitalized at the Mulago National Referral Hospital and Namboole Stadium CTUs. Chi-square or Fishers’ exact test for categorical and Mann–Whitney U-test for numerical were used to determine the association between dependent and independent variables. Results: The study was terminated early because of significant reduction in the number of patients hospitalized with COVID-19 and the closure of Namboole CTU. Of the anticipated 422 participants, we recruited 108 (25.6%). Of this, 58 (53.7%) were female, with a median age of 38 (range: 20– 75) years. Forty-nine (45.4%) had received at least one dose of the COVID-19 vaccine. Fifty-eight (57.3%) of the participants had ever used herbal medicine and the majority had used them in the past 12 months (71.9%, n = 41) either before the diagnosis of COVID-19 (85.4%, n = 35) or after (36.6%, n = 15). Being vaccinated for COVID-19 (adjusted odds ratio (aOR): 3.1, 95% confidence interval (CI): 1.4– 6.8, p = 0.005) and having attained tertiary level of education (aOR: 6.2, 95% CI: 1.7– 23.1, p = 0.006), as well as the accessibility to herbalists (aOR: 31.2, 95% CI: 3.7– 263.2, p = 0.002) were significantly associated with herbal medication use. The majority of participants reported some improvement after using herbal medicine (80.7%, n = 46) and their doctors or nurses asked almost half of the participants about herbal medicine use (49.5%, n = 53). Conclusion: The use of herbal medicines to treat or prevent COVID-19 among hospitalized patients is a widespread practice in Uganda amidst unpublished evidence of their safety and efficacy.Keywords
This publication has 16 references indexed in Scilit:
- Prevalence of use and reported side effects of herbal medicine among adults in Saudi ArabiaComplementary Therapies in Medicine, 2020
- Prevalence and Predictors of Herbal Medicine Use Among Adults in the United StatesJournal of Patient Experience, 2017
- Prevalence and factors associated with use of herbal medicines during pregnancy among women attending postnatal clinics in Gulu district, Northern UgandaBMC Pregnancy and Childbirth, 2016
- Prevalence of herbal medicine use and associated factors among pregnant women attending antenatal care at public health facilities in Hossana Town, Southern Ethiopia: facility based cross sectional studyArchives of Public Health, 2016
- Prevalence of using non prescribed medications in economically deprived rural population of PakistanArchives of Public Health, 2016
- Traditional Herbal Medicine Use Among Hypertensive Patients in Sub-Saharan Africa: A Systematic ReviewCurrent Hypertension Reports, 2014
- Traditional Herbal Medicine Use Associated with Liver Fibrosis in Rural Rakai, UgandaPLOS ONE, 2012
- The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west NigeriaPharmacoepidemiology and Drug Safety, 2010
- Development of an International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q)The Journal of Alternative and Complementary Medicine, 2009
- Who's talking? Communication between health providers and HIV-infected adults related to herbal medicine for AIDS treatment in western UgandaSocial Science & Medicine, 2008